Information between 8th February 2024 - 18th April 2024
Note: This sample does not contain the most recent 2 weeks of information. Up to date samples can only be viewed by Subscribers.
Click here to view Subscription options.
Parliamentary Debates |
---|
Lung Cancer Medicines
17 speeches (1,269 words) Wednesday 14th February 2024 - Lords Chamber Mentions: 1: Baroness Blackwood of North Oxford (Con - Life peer) I declare my interest as chair of Genomics England and a board member at BioNTech. - Link to Speech |
Select Committee Documents |
---|
Tuesday 19th March 2024
Oral Evidence - University of Oxford, and British Private Equity and Venture Capital Association (BVCA) Science and Technology Committee (Lords) Found: We have also created amazing resources: UK Biobank, Genomics England and probably the biggest patient |
Monday 26th February 2024
Oral Evidence - Imperial College London, University College London, Imperial College London, and The University of Edinburgh Preterm Birth - Preterm Birth Committee Found: With Tommy’s, Genomics England is going to invest money to do duo tests, mother and baby, looking |
Monday 12th February 2024
Oral Evidence - Sands, Tommy's, and Borne Preterm Birth - Preterm Birth Committee Found: We are looking at working with Genomics England on that as well. |
Written Answers |
---|
Genomics: China
Asked by: Catherine West (Labour - Hornsey and Wood Green) Monday 26th February 2024 Question to the Cabinet Office: To ask the Minister for the Cabinet Office, whether the Government (a) is taking steps to ensure the security of genetic data of UK citizens and (b) has raised potential concerns relating to Chinese genomics companies as part of the US-UK Strategic Dialogue on Biological Security. Answered by Alex Burghart - Parliamentary Secretary (Cabinet Office) Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource consider national security in decision making about partnerships with other companies. The Office for Life Sciences is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world. This is being conducted in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank. Underpinned by the UK Biological Security Strategy and the U.S. Biodefense Strategy, the U.S.-UK Strategic Dialogue on Biological Security reflects a shared ambition to protect against a growing and diverse spectrum of biological threats. These risks include future pandemics as well as those that might arise from misuse of biotechnology and genomic data by state actors.
|
Secondary Legislation |
---|
Government Resources and Accounts Act 2000 (Estimates and Accounts) Order 2024 This Order designates specified central government bodies in relation to named government departments for the purpose of those departments’ supply estimates and resource accounts. HM Treasury Parliamentary Status - Text of Legislation - Made negative Laid: Thursday 7th March - In Force: 1 Apr 2024 Found: NHS charities as defined by section 149(7) of the Charities Act 2011(3) Expert Advisory Group on AIDS Genomics |
Department Publications - Guidance |
---|
Tuesday 26th March 2024
Department for Science, Innovation & Technology Source Page: Research Ventures Catalyst: successful applications Document: PharosAI (PDF) Found: In discussions with partners such as NHS England, UK Biobank, Royal College of Pathologists, Genomics |
Department Publications - Research |
---|
Monday 11th March 2024
Department of Health and Social Care Source Page: Equity in medical devices: independent review - final report Document: Equity in medical devices: independent review - full report (web accessible) (PDF) Found: Future proofing: polygenic risk scores Equity in Medical Devices: Independent Review 84• Genomics England |
Monday 11th March 2024
Department of Health and Social Care Source Page: Equity in medical devices: independent review - final report Document: Equity in medical devices: independent review - full report (print ready) (PDF) Found: Future proofing: polygenic risk scores Equity in Medical Devices: Independent Review 84• Genomics England |
Department Publications - Transparency |
---|
Tuesday 27th February 2024
HM Treasury Source Page: Supplementary Estimates 2023-24 Document: Supplementary Estimates 2023-24 (web) (PDF) Found: England Limited Professor Matt Westmore Health Research Authority Dr Rosie Benneyworth Health Services |
Tuesday 27th February 2024
HM Treasury Source Page: Supplementary Estimates 2023-24 Document: Supplementary Estimates 2023-24 (print) (PDF) Found: England Limited Professor Matt Westmore Health Research Authority Dr Rosie Benneyworth Health Services |
Non-Departmental Publications - Statistics |
---|
Mar. 27 2024
Government Office for Science Source Page: Human Genome Databases Document: Human Genome Databases PDF (PDF) Statistics Found: Future Health), Catalina Vallejos (Universi ty of Edinburgh), Clive Darwell (UK Biobank), Matt Brown (Genomics |
Non-Departmental Publications - News and Communications |
---|
Feb. 13 2024
Medicines and Healthcare products Regulatory Agency Source Page: Pioneering genetic biobank to start recruiting patients on stroke prevention medicines Document: Pioneering genetic biobank to start recruiting patients on stroke prevention medicines (webpage) News and Communications Found: Card Biobank, a pilot launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics |
Deposited Papers |
---|
Friday 15th March 2024
Department of Health and Social Care Source Page: I. Equity in medical devices: Independent Review. Incl. appendices [Chair, Dame Margaret Whitehead]. 130p. II. Government response to the report of the equity in medical devices: independent review. 64p. Document: Government_response.pdf (PDF) Found: Recently published research jointly funded and carried out by Genomics England is an example of work |
Friday 15th March 2024
Department of Health and Social Care Source Page: I. Equity in medical devices: Independent Review. Incl. appendices [Chair, Dame Margaret Whitehead]. 130p. II. Government response to the report of the equity in medical devices: independent review. 64p. Document: IR_Equity_in_Medical_Devices_Report.pdf (PDF) Found: Future proofing: polygenic risk scores Equity in Medical Devices: Independent Review 84• Genomics England |